title: Retinoids inhibit the respiratory burst and degranulation of stimulated human polymorphonuclear leukocytes.
abstract: Retinoids exhibit a wide spectrum of activities, including antiinflammatory properties. We have investigated the effect of retinoic acid (RA) and retinyl acetate (RAc) on the production of reactive oxygen metabolites and the release of lysosomal enzymes by human polymorphonuclear leukocytes (PMN). Incubation of PMN with RAc or RA (1-100 microM) caused a dose-dependent inhibition (upto 90%) in O2- production and chemiluminescence induced by phorbol myristate acetate (PMA), N-formyl-methionyl-leucyl-phenylanaline (fMLP), opsonized zymosan or ionophore A23187. Both retinoids (1-100 microM) also inhibited, in a dose-dependent way, degranulation induced by fMLP (upto 85% at the highest concentration of RA). These inhibitory effects appear irreversible, since they persist after the drugs are removed and the cells washed before stimulation. Inhibitors of cyclo-oxygenase activity such as acetylsalicyclic acid and indomethacin did not influence the effects of RAc. In contrast, BW755, an inhibitor of both cyclooxygenase and lipoxygenase, reversed the inhibitory action of RAc, suggesting that the effect of retinoids occurs possibly through the mediation of lipoxygenase products. The modulation of PMN oxidative metabolism and degranulation might help explain the antiinflammatory properties of retinoids.
authors.affiliation: Istituto di Patologia Generale, Università di Bari, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Fumarulo
authors.forename: M
authors.initials: M
authors.lastname: Conese
authors.forename: S
authors.initials: S
authors.lastname: Riccardi
authors.forename: D
authors.initials: D
authors.lastname: Giordano
authors.forename: P
authors.initials: P
authors.lastname: Montemurro
authors.forename: M
authors.initials: M
authors.lastname: Colucci
authors.forename: N
authors.initials: N
authors.lastname: Semeraro
mesh_terms: D000001:Calcimycin / Q000494:pharmacology; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D003594:Cytoplasmic Granules / Q000187:drug effects / Q000502:physiology*; D004224:Diterpenes; D006801:Humans; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology; D008163:Luminescent Measurements; D008247:Lysosomes / Q000201:enzymology; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects / Q000502:physiology* / Q000648:ultrastructure; D016897:Respiratory Burst / Q000187:drug effects*; D000084562:Retinyl Esters; D013481:Superoxides / Q000097:blood; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology*; D014801:Vitamin A / Q000031:analogs & derivatives* / Q000494:pharmacology; D015054:Zymosan / Q000494:pharmacology
chemical_list: D016861:Cyclooxygenase Inhibitors; D004224:Diterpenes; D016859:Lipoxygenase Inhibitors; D000084562:Retinyl Esters; D013481:Superoxides; D014801:Vitamin A; D000001:Calcimycin; C009166:retinol acetate; D014212:Tretinoin; D009240:N-Formylmethionine Leucyl-Phenylalanine; D015054:Zymosan; D013755:Tetradecanoylphorbol Acetate